Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

245.80
+5.322.21%
Pre-market: 246.590.7900+0.32%09:09 EDT
Volume:422.91K
Turnover:103.85M
Market Cap:15.96B
PE:16.80
High:246.73
Open:244.60
Low:244.04
Close:240.48
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.77
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.32
PE(LYR):-42.09

Loading ...

Werewolf Therapeutics Posts Q2 Profit on Jazz Asset Sale

Reuters
·
Jul 31

Should Anticipated Earnings Beat and Employer Award Recognition Require Action From Jazz Pharmaceuticals (JAZZ) Investors?

Simply Wall St.
·
Jul 29

Earning Preview: Jazz Pharmaceuticals PLC revenue is expected to increase by 6.51%, and institutional views are bullish

Earnings Agent
·
Jul 27

Jazz Pharmaceuticals (JAZZ) Stock Still Looks Cheap As Shares Jumped 115%

Simply Wall St.
·
Jul 26

Jazz Pharmaceuticals Held Annual Shareholder Meeting in Dublin

Reuters
·
Jul 24

Jazz Pharmaceuticals Plc : Raymond James Raises Target Price to $275 from $239

THOMSON REUTERS
·
Jul 21

Jazz Pharmaceuticals to Report Q2 Financial Results After U.S. Market Close

Reuters
·
Jul 21

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026

THOMSON REUTERS
·
Jul 21

Jazz Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 20

Did Jazz’s Sleep and Oncology Pipeline Momentum Just Shift Jazz Pharmaceuticals' (JAZZ) Investment Narrative?

Simply Wall St.
·
Jul 20

Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts

TIPRANKS
·
Jul 18

Jazz Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17

Jazz Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Gain Therapeutics Names Joanne Taylor Chief Scientific Officer, Promotes Terenzio Ignoni to COO

Reuters
·
Jul 16

Jazz Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

Jazz Pharmaceuticals Plc : Barclays Raises Target Price to $260 from $253

THOMSON REUTERS
·
Jul 14

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Jefferies

TIPRANKS
·
Jul 13

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 10

Jazz Pharmaceuticals Plc : Deutsche Bank Raises Target Price to $270 from $250

THOMSON REUTERS
·
Jul 09